Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Toward personalized sexual medicine (part 1): integrating the "dual control model" into differential drug treatments for hypoactive sexual desire disorder and female sexual arousal disorder.
Bloemers J, van Rooij K, Poels S, Goldstein I, Everaerd W, Koppeschaar H, Chivers M, Gerritsen J, van Ham D, Olivier B, Tuiten A. Bloemers J, et al. Among authors: koppeschaar h. J Sex Med. 2013 Mar;10(3):791-809. doi: 10.1111/j.1743-6109.2012.02984.x. Epub 2012 Nov 6. J Sex Med. 2013. PMID: 23130782
Efficacy and Safety of On-Demand Use of 2 Treatments Designed for Different Etiologies of Female Sexual Interest/Arousal Disorder: 3 Randomized Clinical Trials.
Tuiten A, van Rooij K, Bloemers J, Eisenegger C, van Honk J, Kessels R, Kingsberg S, Derogatis LR, de Leede L, Gerritsen J, Koppeschaar HPF, Olivier B, Everaerd W, Frijlink HW, Höhle D, de Lange RPJ, Böcker KBE, Pfaus JG. Tuiten A, et al. Among authors: koppeschaar hpf. J Sex Med. 2018 Feb;15(2):201-216. doi: 10.1016/j.jsxm.2017.11.226. Epub 2017 Dec 27. J Sex Med. 2018. PMID: 29289554 Free article. Clinical Trial.
Genotype scores predict drug efficacy in subtypes of female sexual interest/arousal disorder: A double-blind, randomized, placebo-controlled cross-over trial.
Tuiten A, Michiels F, Böcker KB, Höhle D, van Honk J, de Lange RP, van Rooij K, Kessels R, Bloemers J, Gerritsen J, Janssen P, de Leede L, Meyer JJ, Everaerd W, Frijlink HW, Koppeschaar HP, Olivier B, Pfaus JG. Tuiten A, et al. Among authors: koppeschaar hp. Womens Health (Lond). 2018 Jan-Dec;14:1745506518788970. doi: 10.1177/1745506518788970. Womens Health (Lond). 2018. PMID: 30016917 Free PMC article. Clinical Trial.
The Effect of Food on the Pharmacokinetics of Sildenafil after Single Administration of a Sublingual Testosterone and Oral Sildenafil Combination Tablet in Healthy Female Subjects.
Bloemers J, Gerritsen J, van Rooij K, de Leede L, van der Geest R, Frijlink HW, Koppeschaar HPF, Olivier B, Tuiten A. Bloemers J, et al. Among authors: koppeschaar hpf. J Sex Med. 2019 Sep;16(9):1433-1443. doi: 10.1016/j.jsxm.2019.06.015. J Sex Med. 2019. PMID: 31488289 Clinical Trial.
The Effect of Food on the Pharmacokinetics of Buspirone After Single Administration of a Sublingual Testosterone and Oral Buspirone Combination Tablet in Healthy Female Subjects.
Gerritsen J, Bloemers J, van Rooij K, de Leede L, van der Geest R, Frijlink HW, Koppeschaar HPF, Olivier B, Tuiten A. Gerritsen J, et al. Among authors: koppeschaar hpf. Sex Med. 2020 Jun;8(2):186-194. doi: 10.1016/j.esxm.2020.01.005. Epub 2020 Feb 20. Sex Med. 2020. PMID: 32088143 Free PMC article.
The influence of testosterone combined with a PDE5-inhibitor on cognitive, affective, and physiological sexual functioning in women suffering from sexual dysfunction.
van der Made F, Bloemers J, Yassem WE, Kleiverda G, Everaerd W, van Ham D, Olivier B, Koppeschaar H, Tuiten A. van der Made F, et al. Among authors: koppeschaar h. J Sex Med. 2009 Mar;6(3):777-90. doi: 10.1111/j.1743-6109.2008.01142.x. Epub 2009 Feb 3. J Sex Med. 2009. PMID: 19207276 Clinical Trial.
Toward personalized sexual medicine (part 3): testosterone combined with a Serotonin1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanisms.
van Rooij K, Poels S, Bloemers J, Goldstein I, Gerritsen J, van Ham D, van Mameren F, Chivers M, Everaerd W, Koppeschaar H, Olivier B, Tuiten A. van Rooij K, et al. Among authors: koppeschaar h. J Sex Med. 2013 Mar;10(3):824-37. doi: 10.1111/j.1743-6109.2012.02982.x. Epub 2012 Nov 6. J Sex Med. 2013. PMID: 23130675 Clinical Trial.
Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues.
Poels S, Bloemers J, van Rooij K, Goldstein I, Gerritsen J, van Ham D, van Mameren F, Chivers M, Everaerd W, Koppeschaar H, Olivier B, Tuiten A. Poels S, et al. Among authors: koppeschaar h. J Sex Med. 2013 Mar;10(3):810-23. doi: 10.1111/j.1743-6109.2012.02983.x. Epub 2012 Nov 6. J Sex Med. 2013. PMID: 23130748 Clinical Trial.
193 results